Home/Filings/4/0001209191-20-003239
4//SEC Filing

GARCEAU ROGER 4

Accession 0001209191-20-003239

CIK 0001359931other

Filed

Jan 12, 7:00 PM ET

Accepted

Jan 13, 7:18 PM ET

Size

10.9 KB

Accession

0001209191-20-003239

Insider Transaction Report

Form 4
Period: 2020-01-09
Transactions
  • Award

    Common Stock

    2020-01-10+33,00033,000 total
  • Award

    Stock Option (Right to Buy)

    2020-01-09+12,39912,399 total
    Exercise: $9.18Exp: 2028-12-31Common Stock (12,399 underlying)
  • Award

    Stock Option (Right to Buy)

    2020-01-09+10,49110,491 total
    Exercise: $9.18Exp: 2029-04-28Common Stock (10,491 underlying)
Footnotes (6)
  • [F1]The shares being reported are being issued pursuant to restricted stock unit awards ("RSUs"), each one of which represents a contingent right to receive one share of the Issuer's common stock. 3/24th of the shares were vested upon grant and 1/24th of the shares vest monthly thereafter, beginning on February 10, 2020. Settlement for the RSUs is deferred until the earliest to occur of (i) the Reporting Person's termination of service, (ii) death, (iii) disability and (iv) a change in control of the Issuer. In the event of a change in control of the Issuer, the RSUs will vest in full.
  • [F2]On September 23, 2019, the Issuer entered into an Agreement and Plan of Merger and Reorganization (the "Merger Agreement") as amended on November 19, 2019, with the Issuer, REM 1 Acquisition, Inc. ("Merger Sub") and ArTara Subsidiary, Inc. ("ArTara Sub"). On January 9, 2020 (the "Effective Time"), Merger Sub was merged with and into ArTara Sub, with ArTara Sub surviving as a wholly owned subsidiary of the Issuer.
  • [F3]1/48th of the shares subject to the option shall vest monthly thereafter for so long as the Reporting Person provides continuous service to the Issuer.
  • [F4]Received in the Merger in exchange for a stock option to acquire 65,000 shares of ArTara Sub common stock for $1.75 per share.
  • [F5]1/48th of the shares subject to the option shall vest monthly following April 29, 2019, for so long as the Reporting Person provides continuous service to the Issuer.
  • [F6]Received in the Merger in exchange for a stock option to acquire 55,000 shares of ArTara Sub common stock for $1.75 per share.

Issuer

ArTara Therapeutics, Inc.

CIK 0001359931

Entity typeother

Related Parties

1
  • filerCIK 0001451767

Filing Metadata

Form type
4
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 7:18 PM ET
Size
10.9 KB